2016 Top Ten Trend Forecasts in the Medical Field

2015 is nearing completion, and Frost & Sullivan's experts and opinion leaders have made the following ten predictions for the 2016 medical sector:

1. Market sales of new generation wearable devices will reach 6 billion US dollars

The sensing, capture and analysis capabilities of the new generation of wearable devices will be enhanced and will therefore be more suitable for clinical use. Currently, wearable medical devices (such as those developed by Vital Connect and Proteus Digital Health) are mainly used for monitoring technology. As technology continues to evolve, next-generation devices that support treatment will continue to receive market support, such as Quell, developed by Neurometrix.

A recent Frost & Sullivan study on consumer behavior and digital healthcare shows that about 24% of consumers currently use mobile apps to track personal health, 16% use wearable sensors, and use individuals. The consumer of electronic medical records has reached approximately 29%. It is predicted that this trend will continue in the near future, and the proportion of consumers using wearable devices may rise to 47%.

2. Retail medical care will gain mainstream status and clinic coverage will be expanded to 35%

In 2015, a large part of the investment in the retail industry was used to expand the coverage of clinics, acquire new medical tools, and establish business partnerships with medical companies. Based on this, in 2016, in order to meet their ambitions to become the forefront of primary medical services, retailers will make great efforts to fully implement their development and expansion strategies.

3. The New Development Bank will increase investment in the medical field, which will change the development momentum of many countries.

The newly developed bank (formerly the BRICS Bank) has a capital of up to $100 billion and is a strong opponent of other World Bank organizations controlled by major US and European shareholders. The bank is committed to improving the living standards of people in developing countries, and its main programs include providing funds to build medical infrastructure for those with weak medical conditions.

4. Private health insurance business is expanding rapidly in India and will open up new markets

As of March 2014, Indian health insurance coverage was only 17%. Therefore, people spend a lot of money on medical treatment, and the burden is very heavy. The part at their own expense exceeds 75%. The new Indian government has adopted a strategy of prioritizing medical care and has implemented a national health insurance plan that not only provides free medicines and diagnostic services to the public, but also helps individuals enjoy cheap insurance.

5. Population health will drive more than $50 billion in medical enterprise mergers and acquisitions

It is estimated that the company's long-term strategy related to population health management will be the driving factor for corporate restructuring, mergers and acquisitions, capital extraction, and R&D investment.

The demand for population health tools has forced companies to consider their acquisition strategy from another perspective, which has the effect that business volume between companies near the market or complementary markets will increase.

6. Medical site testing (POC) becomes more timely and costs are reduced, which may lead to new diagnostic models

New medical site detection platforms have been given new features such as molecular POC, connectivity features, biosensors, and microfluidic systems. If these new platforms are applied to the actual operation and commercialized, the doctor's turnaround time will be greatly improved (from 5 minutes to 15 minutes), and the testing service can be carried out at the location of the incident, which was previously impossible. .

Biochemical Pharmaceuticals

Injectable Insulin,Glutathione Lyophilized,Equine Tetanus Antitoxin,Tetanus Antitoxin Injection

NINGBO VOICE BIOCHEMIC CO. LTD , https://www.medicine-voice.com